The active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimers's disease

Acta Neuropathologica

Volumn 103, Issue 2, 2002, Pages 91-99

  Leroy, Karelle ^a   Boutajangout, Allal ^a   Authelet, M ^a   Woodgett, James R ^b   Anderton, Brian H ^c   Brion, Jean Pierre ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimers's disease; Glycogen synthase kinase 3 ; Granulovacuolar degeneration; Neurofibrillary tangles; Tau

Indexed keywords

ANTIBODY; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; ISOPROTEIN; RECOMBINANT ENZYME; SERINE; TAU PROTEIN; THREONINE;

AGED; AGING; ALZHEIMER DISEASE; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; CASE REPORT; CELL DEATH; CELL GRANULE; CELL SUBPOPULATION; CELL VACUOLE; CONTROLLED STUDY; EXON; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NEUROFIBRILLARY TANGLE; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; GRANULOCYTES; HIPPOCAMPUS; HUMANS; NERVE DEGENERATION; PARAHIPPOCAMPAL GYRUS; TAU PROTEINS; VACUOLES;

EID: 0036942638     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010100435     Document Type: Article

References (49)

1. Ball MJ (1978) Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study. Acta Neuropathol (Berl) 42:73-80
2. 216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci USA 97:11074-11079
3. Bondareff W, Wischik CM, Novak M, Roth M (1991) Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease. Am J Pathol 139:641-647
4. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
5. Brion JP, Hanger DP, Bruce MT, Couck AM, Flament-Durand J, Anderton BH (1991) Tau in Alzheimer neurofibrillary tangles: N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. Biochem J 273:127-133
6. Brion JP, Hanger DP, Couck AM, Anderton BH (1991) A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities. Biochem J 279:831-836
7. Dayanandan R, Van Slegtenhorst M, Mack TGA, Ko L, Yen SH, Leroy K, Brion JP, Anderton BH, Hutton M, Lovestone S (1999) Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett 446:228-232
8. Dickson D, Ksiezak-Reding H, Davies P, Yen S (1987) A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration. Acta Neuropathol (Berl) 73:254-258
9. Dickson DW, Liu W-K, Kress Y, Ku J, DeJesus O, Yen S-HC (1993) Phosphorylated tau immunoreactivity of granulovacuolar bodies (GVB) of Alzheimer's disease: localization of two amino-terminal tau epitopes in GVB. Acta Neuropathol 85: 463-470
10. Drewes G, Ebneth A, Preuss U, Mandelkow EM, Mandelkow E (1997) MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89:297-308
11. Funato H, Enya M, Yoshimura M, Morishima-Kawashima M, Ihara Y (1999) Presence of sodium dodecyl sulfate-stable amyloid β-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation. Am J Pathol 155:23-28
12. Ghoshal N, Smiley JF, DeMaggio AJ, Hoekstra MF, Cochran EJ, Binder LI, Kuret J (1999) A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease. Am J Pathol 155:1163-1172
13. Godemann R, Biernat J, Mandelkow E, Mandelkow EM (1999) Phosphorylation of tau protein by recombinant GSK-3β: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain. FEBS Lett 454:157-164
14. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filaments epitopes and neuronal localization of the kinase. Neurosci Lett 147:58-62
15. Harr SD, Hollister RD, Hyman BT (1996) Glycogen synthase kinase 3α and 3β do not colocalize with neurofibrillary tangles. Neurobiol Aging 17:343-348
16. Hoffmann R, Lee VMY, Leight S, Varga I, Otvos L Jr (1997) Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Biochemistry 36:8114-8124
17. Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J 12:803-808
18. Joachim CL, Morris JH, Selkoe DJ, Kosik KS (1987) Tau epitopes are incorporated into a range of lesions in Alzheimer's disease. J Neuropathol Exp Neurol 46:611-622
19. Kahn J, Anderton B, Probst A, Ulrich J, Esiri M (1985) Immunohistological study of granulovacuolar degeneration using monoclonal antibodies to neurofilaments. J Neurol Neurosurg Psychiatry 48:924-926
20. Leroy K, Brion JP (1999) Developmental expression and localization of glygogen synthase-kinase 3β in rat brain. J Chem Neuroanat 16:279-293
21. Leroy K, Menu R, Conreur JL, Dayanandan R, Lovestone S, Anderton BH, Brion JP (2000) The function of the microtubule-asociated protein tau is variably modulated by graded changes in glycogen synthase kinase-3β activity. FEBS Lett 465:34-38
22. Lesort M, Jope RS, Johnson GVW (1999) Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3β and Fyn tyrosine kinase. J Neurochem 72:576-584
23. Love S, Saitoh T, Quijada S, Cole GM, Terry RD (1988) Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 47:393-405
24. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo J-M, Hanger D, Mulot S, Marquardt B, Stabel S, Woodgett JR, Miller CCJ (1994) Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4:1077-1086
25. Lübke U, Mercken M, Vandermeeren M, Ceuterick-de-Groote C, Vanmechelen E, Martin J, Cras P (1993) Comparative study of granulovacuolar degeneration in neurodegenerative diseases. Adv Biosci 87:149-150
26. Mercken M, Vandermeeren M, Lübke U, Six J, Boons J, Van De Voorde A, Martin JJ, Gheuens J (1992) Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 84: 265-272
27. Moreno FJ, Medina M, Pérez M, De Garcini EM, Avila J (1995) Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine-262 in the presence of heparin (or tubulin). FEBS Lett 372:65-68
28. Okamoto K, Hirai S, Iizuka T, Yanagisawa T, Watanabe M (1991) Reexamination of granulovacuolar degeneration. Acta Neuropathol 82:340-345
29. Oyanagi S, Ikuta F (1974) An ultrastructural observation on granulovacuolar degenerations in reference to the process of their formation. Brain Nerve (Tokyo) 26:783-788
30. Pap M, Cooper GM (1998) Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 273:19929-19932
31. Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56:70-78
32. Price D, Altshuler R, Struble R, Casanova M, Cork L, Murphy D (1986) Sequestration of tubulin in neurons in Alzheimer's disease. Brain Res 385:305-310
33. Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH (2000) Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3β. J Neurochem 74:1587-1595
34. 262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem 270:18917-18922
35. Shirazi SK, Wood JG (1993) The protein tyrosine kinase, fyn, in Alzheimer's disease pathology. NeuroReport 4:435-437
36. Shiurba RA, Ishiguro K, Takahashi M, Sato K, Spooner ET, Mercken M, Yoshida R, Wheelock TR, Yanagawa H, Imahori K, Nixon RA (1996) Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology. Brain Res 737:119-132
37. Simchowicz, T (1911) Histopathologische Studien über die senile Demenz. Histologie und histopathologishe Arbeiten. In: Nissl F, Alzheimer A (eds) Über die Groβhirnrinde. Fischer, Jena, pp 267-444
38. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Brück W, Jellinger K, Lassmann H (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease - Evidence for apoptotic cell death. Am J Pathol 155:1459-1466
39. Sutherland C, Leighton IA, Cohen P (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296:15-19
40. Takashima A, Noguchi K, Michel G, Mercken M, Hoshi M, Ishiguro K, Imahori K (1996) Exposure of rat hippocampal neurons to amyloid β peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I glycogen synthase kinase-3β. Neurosci Lett 203:33-36
41. Terry RD, Wisniewski HM (1972) Ultrastructure of senile dementia and of experimental analogs. In: Gaintz C M (ed) Aging and the brain. Plenum Press, New York, pp 89-115
42. Tomlinson B, Kitchener D (1972) Granulovacuolar degeneration of hippocampal pyramidal cells. J Pathol 106:165-185
43. Welsh G, Wilson C, Proud C (1996) GSK-3: a SHAGGY frog story. Trends Cell Biol 6:274-279
44. Woodard J (1962) Clinicopathologic significance of granulovacuolar degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 21:85-91
45. Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3/Factor A. EMBO J 9:2431-2438
46. Xu M, Shibayama H, Kobayashi H, Yamada K, Ishihara R, Zhao P, Takeuchi T, Yoshida K, Inagaki T, Nokura K (1992) Granulovacuolar degeneration in the hippocampal cortex of aging and demented patients - A quantitative study. Acta Neuropathol 85:1-9
47. Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, Imahori K (1996) Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK)I glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol 92:232-241
48. A/glycogen synthase kinase-3α after heparin potentiation phosphorylates τ on sites abnormally phosphorylated in Alzheimer's disease brain. J Neurochem 63:1416-1425
49. Zheng-Fischhöfer QY, Biernat J, Mandelkow EM, Illenberger S, Godemann R, Mandelkow E (1998) Sequential phosphorylation of Tau by glycogen synthase kinase-3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem